Skip to search form
Skip to main content
Semantic Scholar's Logo
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Anti-IGF-1R Human Monoclonal Antibody AMG-479
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
Exposure-response (E-R) analysis to facilitate phase III (P3) dose selection for AMG 479 (A479) in combination with gemcitabine (G) to treat metastatic pancreatic cancer (mPC).
Journal of clinical oncology : official journal…
Corpus ID: 28359485
263 Background: A479 is an investigational, fully human monoclonal antibody against IGF1R. In a phase II study, 125 pts with mPC…
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE